Fielmann Aktiengesellschaft (FLMNF)
USD 46.75
(-1.23%)
USD 46.75
(-1.23%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 224.74 Million EUR | 14.59% |
| 2022 | 196.11 Million USD | 12.73% |
| 2021 | 173.97 Million USD | -3.32% |
| 2020 | 179.95 Million USD | 1.0% |
| 2019 | 178.16 Million USD | 30.71% |
| 2018 | 136.3 Million EUR | 5.93% |
| 2017 | 128.67 Million EUR | 0.42% |
| 2016 | 128.13 Million EUR | -3.74% |
| 2015 | 133.1 Million EUR | 8.57% |
| 2014 | 122.6 Million EUR | 12.64% |
| 2013 | 108.84 Million EUR | 10.84% |
| 2012 | 98.19 Million EUR | 1.33% |
| 2011 | 96.9 Million EUR | 3.55% |
| 2010 | 93.58 Million EUR | 4.31% |
| 2009 | 89.71 Million EUR | -14.15% |
| 2008 | 104.5 Million EUR | 8.48% |
| 2007 | 96.33 Million EUR | 11.91% |
| 2006 | 86.08 Million EUR | 8.24% |
| 2005 | 79.53 Million EUR | 9.66% |
| 2004 | 72.52 Million EUR | -2.16% |
| 2003 | 74.12 Million EUR | -6.11% |
| 2002 | 78.95 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 240 Million EUR | 0.0% |
| 2023 Q4 | 224.74 Million EUR | 0.0% |
| 2023 FY | 224.74 Million EUR | 14.59% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | 218.9 Million USD | 11.62% |
| 2023 Q2 | 228.6 Million USD | 4.43% |
| 2022 Q3 | 182.34 Million USD | 4.56% |
| 2022 Q1 | 169.98 Million EUR | 11.06% |
| 2022 Q2 | 174.39 Million EUR | 2.6% |
| 2022 Q4 | 196.11 Million USD | 7.55% |
| 2022 FY | 196.11 Million USD | 12.73% |
| 2021 Q1 | 155.57 Million EUR | 5.78% |
| 2021 FY | 173.97 Million USD | -3.32% |
| 2021 Q4 | 153.06 Million EUR | -1.83% |
| 2021 Q2 | 158.72 Million EUR | 2.02% |
| 2021 Q3 | 155.92 Million EUR | -1.77% |
| 2020 Q1 | 164.38 Million EUR | 3.57% |
| 2020 Q2 | 168.45 Million EUR | 2.47% |
| 2020 Q3 | 162.13 Million EUR | -3.75% |
| 2020 Q4 | 147.07 Million EUR | -9.29% |
| 2020 FY | 179.95 Million USD | 1.0% |
| 2019 FY | 178.16 Million USD | 30.71% |
| 2019 Q2 | 151.75 Million EUR | 1.05% |
| 2019 Q3 | 154.54 Million EUR | 1.83% |
| 2019 Q1 | 150.18 Million EUR | 10.18% |
| 2019 Q4 | 158.72 Million EUR | 2.71% |
| 2018 Q3 | 132.89 Million EUR | 3.64% |
| 2018 Q4 | 136.3 Million EUR | 2.57% |
| 2018 FY | 136.3 Million EUR | 5.93% |
| 2018 Q1 | 131.42 Million EUR | 2.13% |
| 2018 Q2 | 128.22 Million EUR | -2.43% |
| 2017 Q1 | 146.42 Million EUR | 14.28% |
| 2017 Q4 | 128.67 Million EUR | -4.09% |
| 2017 Q3 | 134.16 Million EUR | -4.76% |
| 2017 FY | 128.67 Million EUR | 0.42% |
| 2017 Q2 | 140.86 Million EUR | -3.8% |
| 2016 Q2 | 139.05 Million EUR | -2.2% |
| 2016 FY | 128.13 Million EUR | -3.74% |
| 2016 Q3 | 130.21 Million EUR | -6.35% |
| 2016 Q4 | 128.13 Million EUR | -1.6% |
| 2016 Q1 | 142.18 Million EUR | 6.82% |
| 2015 FY | 133.1 Million EUR | 8.57% |
| 2015 Q2 | 140.13 Million EUR | -1.23% |
| 2015 Q3 | 134.98 Million EUR | -3.68% |
| 2015 Q4 | 133.1 Million EUR | -1.39% |
| 2015 Q1 | 141.87 Million EUR | 15.72% |
| 2014 Q1 | 123.4 Million EUR | 13.37% |
| 2014 FY | 122.6 Million EUR | 12.64% |
| 2014 Q3 | 124.38 Million EUR | 1.37% |
| 2014 Q2 | 122.7 Million EUR | -0.57% |
| 2014 Q4 | 122.6 Million EUR | -1.43% |
| 2013 Q1 | 111.2 Million EUR | 13.25% |
| 2013 FY | 108.84 Million EUR | 10.84% |
| 2013 Q3 | 109.56 Million EUR | -1.71% |
| 2013 Q2 | 111.46 Million EUR | 0.23% |
| 2013 Q4 | 108.84 Million EUR | -0.65% |
| 2012 FY | 98.19 Million EUR | 1.33% |
| 2012 Q3 | 105.71 Million EUR | -2.37% |
| 2012 Q4 | 98.19 Million EUR | -7.11% |
| 2012 Q2 | 108.28 Million EUR | -0.93% |
| 2012 Q1 | 109.29 Million EUR | 12.78% |
| 2011 Q3 | 101.31 Million EUR | -1.65% |
| 2011 Q4 | 96.9 Million EUR | -4.35% |
| 2011 FY | 96.9 Million EUR | 3.55% |
| 2011 Q1 | 105.45 Million EUR | 12.69% |
| 2011 Q2 | 103.01 Million EUR | -2.31% |
| 2010 Q2 | 118.87 Million EUR | -0.67% |
| 2010 Q4 | 93.58 Million EUR | -17.49% |
| 2010 Q1 | 119.68 Million EUR | 33.4% |
| 2010 Q3 | 113.41 Million EUR | -4.59% |
| 2010 FY | 93.58 Million EUR | 4.31% |
| 2009 FY | 89.71 Million EUR | -14.15% |
| 2009 Q4 | 89.71 Million EUR | 0.0% |
| 2008 FY | 104.5 Million EUR | 8.48% |
| 2007 FY | 96.33 Million EUR | 11.91% |
| 2006 FY | 86.08 Million EUR | 8.24% |
| 2005 FY | 79.53 Million EUR | 9.66% |
| 2004 FY | 72.52 Million EUR | -2.16% |
| 2003 FY | 74.12 Million EUR | -6.11% |
| 2002 FY | 78.95 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -167830.718% |
| Ansell Limited | 457.04 Million USD | 50.827% |
| Ansell Limited | 457.9 Million USD | 50.919% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -418.603% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -805708.534% |
| Psykey, Inc. | 49.94 Thousand USD | -449920.024% |
| ConvaTec Group Plc | 395.54 Million USD | 43.182% |
| ConvaTec Group Plc | 396.1 Million USD | 43.262% |
| Encision Inc. | 1.4 Million USD | -15926.094% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 2418219.217% |
| LifePoint, Inc. | 2.3 Million USD | -9631.772% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -9252.476% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -50861.451% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -244496.33% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -23014.432% |
| SmileDirectClub, Inc. | 49.87 Million USD | -350.616% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 36.108% |
| SheerVision, Inc. | 339.66 Thousand USD | -66065.582% |
| United Health Products, Inc. | 33.59 Thousand USD | -668808.864% |
| Vasamed, Inc. | 449.02 Thousand USD | -49950.331% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -2626901.753% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -69657.553% |